ARCHIVES

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

Groups Warn Against Cuts In Research, Seek Funds For NCI

February 10, 1995

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013